[PS3-1] First-line nivolumab plus ipilimumab or chemotherapy for advanced ESCC: A Japanese subanalysis of CheckMate 648
Abstract password authentication.
The password can be found on page 27 of the program book.
Presidential Session
Fri. Feb 18, 2022 8:20 AM - 10:35 AM Room 1 (Main Hall, 1F, Kyoto International Conference Center)
Chair:Chikashi Ishioka(Department of Clinical Oncology, Tohoku University Graduate School of Medicine),Ian Chau(Department of Medicine, Royal Marsden Hospital, London&Surrey, United Kingdom)
Discussant:Sun Young Rha(Yonsei Cancer Center, Yonsei University),Yasuo Hamamoto(Keio Cancer Center, Keio University School of Medicine),Ian Chau(Department of Medicine, Royal Marsden Hospital, London &Surrey, United Kingdom),Kenro Hirata(Cancer Center, Keio University),Zev A. Wainberg(UCLA School of Medicine),Kentaro Yamazaki(Shizuoka Cancer Center Division of gastrointestinal oncology),Eric Van Cutsem(University Hospitals Gasthuisberg / Leuven & KULeuven),Hironaga Satake(Department of Medical Oncology, Kochi Medical School),Yoo Changhoon(Asan Medical Center),Etsuro Hatano(Department of Surgery, Graduate School of Medicine, Kyoto University)
Abstract password authentication.
The password can be found on page 27 of the program book.